The analgesic effect of thymoquinone in the reserpine-induced experimental fibromyalgia model
Cukurova Anestezi ve Cerrahi Bilimler Dergisi · 30.06.2026 · 9 (2) · 349-354
DOI: 10.36516/jocass.1883533 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cukurova Anestezi ve Cerrahi Bilimler Dergisi, online erschienen am 30.06.2026. Verfasst von Mehmet Sargın und 3 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben.
Abstract (Originalsprache)
Aim
Fibromyalgia is a chronic pain syndrome characterized by widespread pain and sensory hypersensitivity, for which effective and well-tolerated treatments remain limited. This study aimed to evaluate the analgesic effect of thymoquinone (TQ) in a reserpine-induced experimental fibromyalgia model in rats.
Methods
Male Wistar rats were randomly allocated into three groups (n = 6 per group): control, reserpine, and reserpine + thymoquinone. Fibromyalgia-like pain was induced by subcutaneous administration of reserpine (1 mg/kg) once daily for three consecutive days. Thymoquinone (100 mg/kg) was administered orally four days after the final reserpine injection. Mechanical allodynia and thermal hyperalgesia were assessed using the von Frey filament test and the hot-plate test, respectively, at baseline and at 30, 60, 120, and 180 minutes following treatment. Behavioral assessments were performed by an investigator blinded to group allocation. Non-parametric statistical analyses were applied.
Results
Baseline mechanical and thermal nociceptive thresholds did not differ significantly among groups. Thymoquinone treatment resulted in a significant increase in mechanical withdrawal thresholds compared with both control and reserpine-only groups at 60, 120, and 180 minutes (p < 0.01), indicating a marked attenuation of reserpine-induced mechanical allodynia. In contrast, no statistically significant differences were observed between groups in hot-plate latency times at any time point, although numerically higher latencies were noted in the thymoquinone-treated group at later assessments.
Conclusions
Thymoquinone exerts a significant analgesic effect on mechanical allodynia in a reserpine-induced fibromyalgia model, suggesting its potential as a novel therapeutic agent for fibromyalgia-associated pain. Further studies are warranted to clarify its mechanism of action and modality-specific analgesic profile.
Zitieren
APA
Sargın, M., Yurteri, B. G., Değirmencioğlu, S., & Uluer, M. S. (2026). The analgesic effect of thymoquinone in the reserpine-induced experimental fibromyalgia model. Cukurova Anestezi ve Cerrahi Bilimler Dergisi, 9(2), 349-354. https://doi.org/10.36516/jocass.1883533
Vancouver
Sargın M, Yurteri BG, Değirmencioğlu S, Uluer MS. The analgesic effect of thymoquinone in the reserpine-induced experimental fibromyalgia model. Cukurova Anestezi ve Cerrahi Bilimler Dergisi. 2026;9(2):349-354. doi:10.36516/jocass.1883533
BibTeX
@article{Sargn2026,
author = {Sargın, Mehmet and Yurteri, Burcu Gezer and Değirmencioğlu, Sinan and Uluer, Mehmet Selçuk},
title = {The analgesic effect of thymoquinone in the reserpine-induced experimental fibromyalgia model},
journal = {Cukurova Anestezi ve Cerrahi Bilimler Dergisi},
year = {2026},
volume = {9},
number = {2},
pages = {349--354},
doi = {10.36516/jocass.1883533}
}
EUVIMED